Martin Hoenigl, M.D., Ass. Prof., FECMM is holding an appointment as assistant adjunct professor at the Division of Infectious Diseases of the University of California, San Diego (UCSD). He has obtained his venia docendi in internal medicine in 2012, and is author to 185
pub med listed publications in the field of infectious diseases, the majority in leading authorships (i.e. first or last author; ORCiD: 0000-0002-1653-2824). His research is focusing on Acute HIV infection and HIV prevention, and also Clinical Mycology. Dr. Hoenigl has been awarded with the Researcher of the year 2011 award at the Medical University of Graz, and with the Research Promotion award 2014 of the German Speaking mycological society.
At the completion of this educational session, learners will:
- Understand Dating App usage patterns: Who uses what and how much.
- Understand associations between Dating App use and real-world HIV risk and prevention behaviors.
- Realize the potential for GrindrTM and other Dating Apps to serve as platforms for education and HIV Prevention Outreach.
This CME activity has approved for AMA PRA Category 1 Credit™
for May 13, 2020 as a live activity. This activity will also be available as an enduring activity from May 14, 2020, through May 12, 2023.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
- Dr. William M. Valenti (Moderator/Course Director) has no relevant financial relationships to disclose.
- Dr. Martin Hoenigl (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Grant funding from Gilead. Dr. Hoenigl will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation